Vita Life Sciences (ASX:VLS) FCF Margin % : 8.26% (As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Vita Life Sciences FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Vita Life Sciences's Free Cash Flow for the six months ended in Dec. 2024 was A$3.31 Mil. Vita Life Sciences's Revenue for the six months ended in Dec. 2024 was A$40.05 Mil. Therefore, Vita Life Sciences's FCF Margin % for the quarter that ended in Dec. 2024 was 8.26%.

As of today, Vita Life Sciences's current FCF Yield % is 6.32%.

The historical rank and industry rank for Vita Life Sciences's FCF Margin % or its related term are showing as below:

ASX:VLS' s FCF Margin % Range Over the Past 10 Years
Min: 3.41 Med: 8.73 Max: 16.62
Current: 7.49

During the past 13 years, the highest FCF Margin % of Vita Life Sciences was 16.62%. The lowest was 3.41%. And the median was 8.73%.

ASX:VLS's FCF Margin % is ranked better than
67.84% of 970 companies
in the Drug Manufacturers industry
Industry Median: 0.915 vs ASX:VLS: 7.49

Vita Life Sciences FCF Margin % Historical Data

The historical data trend for Vita Life Sciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vita Life Sciences FCF Margin % Chart

Vita Life Sciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

16.04

10.04

3.94

16.62

7.49

Vita Life Sciences Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
FCF Margin %	Get a 7-Day Free Trial															7.85	12.91	19.87	6.71	8.26

Competitive Comparison of Vita Life Sciences's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Vita Life Sciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vita Life Sciences's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vita Life Sciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Vita Life Sciences's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Vita Life Sciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Vita Life Sciences's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	5.957	/	79.505
	=	7.49 %

Vita Life Sciences's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	3.308	/	40.054
	=	8.26 %

Vita Life Sciences FCF Margin % Related Terms

Thank you for viewing the detailed overview of Vita Life Sciences's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vita Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vita Life Sciences Ltd (ASX:VLS) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bath Road Kirrawee, Unit 1/ 102, Sydney, NSW, AUS, 2232

Website

https://www.vitalifesciences.com

Vita Life Sciences Ltd is an Australian based pharmaceutical and healthcare company involved in formulating, packaging, sales, and distribution of vitamins and supplements. The company produces a wide range of premium supplements, vitamins, minerals, herbs and superfoods catered to all age categories and health conditions. The company markets its products through pharmacies and health food stores under the VitaHealth, Herbs of Gold brands throughout Asia-Pacific region. The company has four reportable segments which include The Australia segment comprises of sale of Herbs of Gold range in Australia and exports into China. The Singapore and Malaysia segment, comprise of Vitahealth and Herbs of Gold range in both countries The other market segment comprises of Vitahealth ranges.

Vita Life Sciences Headlines

No Headlines